Foucan Lydia, Deloumeaux Jacqueline, Hue Kheira, Foucan Tania, Blanchet-Deverly Anne, Merault Henry, Gabriel Jean-Marc, Hiesse Christian
Research group Clinical Epidemiology and Medicine of the University of Antilles and Guyane.
Am J Hypertens. 2005 Nov;18(11):1457-62. doi: 10.1016/j.amjhyper.2005.05.028.
The aims of this study were to examine systolic BP (SBP), diastolic BP (DBP), mean arterial pressure (MAP), and pulse pressure (PP) in patients with type 2 diabetes undergoing hemodialysis (HD), and to assess the relationships between these parameters and cardiovascular (CV) events such as coronary heart disease and congestive cardiac failure.
A total of 80 Afro-Caribbean type 2 diabetic patients undergoing hemodialysis in three centers in Guadeloupe, French West Indies, were included in this cross-sectional study. Pre- and postdialysis BP were recorded. Logistic regression methods and areas under the receiver operating characteristic curves were used.
The mean age (+/- standard deviation) was 62.2 years (+/-10.2 years). A total of 24 subjects (30%) had one or more CV events. Sixteen (20%) had coronary disease, 15 (18.8%) cardiac failure, and seven (8.8%) had both. The medians [interquartile ranges] for predialysis PP was higher in patients with CV comorbidity than in patients without a history of CV at 84.5 mm Hg [74.5 to 92.3]v 69.5 mm Hg [61.0 to 79.5], P = .003. Areas under the ROC curves (95% confidence intervals) predialysis were significant only for SBP and PP at 0.70 (0.58 to 0.82) v 0.71 (0.59 to 0.83) without statistical differences. After adjustment for gender, age, body mass index, antihypertensive use, time on hemodialysis (>or=2 years), and hemoglobin rate, the odds ratio was significant only predialysis, and a higher odds ratio was found for PP at 2.25 (1.22 to 4.18), P = .01, than for SBP 1.97 (1.12 to 3.49), P = .02.
Our results suggest that the strongest association of PP with CV morbidities should be considered in therapeutic strategies. These results show the necessity of targeting antihypertensive treatment to patients' predialysis blood pressure values.
本研究旨在检测接受血液透析(HD)的2型糖尿病患者的收缩压(SBP)、舒张压(DBP)、平均动脉压(MAP)和脉压(PP),并评估这些参数与心血管(CV)事件如冠心病和充血性心力衰竭之间的关系。
本横断面研究纳入了法属西印度群岛瓜德罗普岛三个中心的80例接受血液透析的非裔加勒比2型糖尿病患者。记录透析前后的血压。使用逻辑回归方法和受试者工作特征曲线下面积。
平均年龄(±标准差)为62.2岁(±10.2岁)。共有24名受试者(30%)发生了一次或多次CV事件。16名(20%)患有冠心病,15名(18.8%)患有心力衰竭,7名(8.8%)两者都有。有CV合并症的患者透析前PP的中位数[四分位间距]高于无CV病史的患者,分别为84.5 mmHg[74.5至92.3]和69.5 mmHg[61.0至79.5],P = 0.003。透析前ROC曲线下面积(95%置信区间)仅SBP和PP有意义,分别为0.70(0.58至0.82)和0.71(0.59至0.83),无统计学差异。在调整性别、年龄、体重指数、抗高血压药物使用、血液透析时间(≥2年)和血红蛋白率后,仅透析前优势比有意义,PP的优势比为2.25(1.22至4.18),P = 0.01,高于SBP的1.97(1.12至3.49),P = 0.02。
我们的结果表明,在治疗策略中应考虑PP与CV发病率之间最强的关联。这些结果表明针对患者透析前血压值进行抗高血压治疗的必要性。